111 related articles for article (PubMed ID: 2160512)
1. Increased lipolytic sensitivity to catecholamines in diabetic patients with severe autonomic neuropathy.
Wahrenberg H; Arner P; Adamsson U; Lins PE; Juhlin-Dannfelt A; Ostman J
J Intern Med; 1990 May; 227(5):309-16. PubMed ID: 2160512
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.
Bolinder J; Sjöberg S; Arner P
Diabetologia; 1996 Jul; 39(7):845-53. PubMed ID: 8817110
[TBL] [Abstract][Full Text] [Related]
3. Abnormal action of catecholamines on lipolysis in adipocytes of type I diabetic patients treated with insulin.
Wahrenberg H; Lönnqvist F; Engfeldt P; Arner P
Diabetes; 1989 Apr; 38(4):524-33. PubMed ID: 2647559
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular, metabolic, and hormonal responses to noradrenaline in diabetic patients with autonomic neuropathy.
Dejgaard A; Andersen P; Hvidberg A; Hilsted J
Diabet Med; 1996 Nov; 13(11):983-9. PubMed ID: 8946158
[TBL] [Abstract][Full Text] [Related]
5. Beta 3-adrenoceptors in dog adipose tissue: studies on their involvement in the lipomobilizing effect of catecholamines.
Galitzky J; Reverte M; Carpene C; Lafontan M; Berlan M
J Pharmacol Exp Ther; 1993 Jul; 266(1):358-66. PubMed ID: 8101220
[TBL] [Abstract][Full Text] [Related]
6. Lipolytic responsiveness to epinephrine in nondiabetic and diabetic humans.
Divertie GD; Jensen MD; Cryer PE; Miles JM
Am J Physiol; 1997 Jun; 272(6 Pt 1):E1130-5. PubMed ID: 9227461
[TBL] [Abstract][Full Text] [Related]
7. Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells.
Engfeldt P; Hellmér J; Wahrenberg H; Arner P
J Biol Chem; 1988 Oct; 263(30):15553-60. PubMed ID: 2844816
[TBL] [Abstract][Full Text] [Related]
8. Defective activation of skeletal muscle and adipose tissue lipolysis in type 1 diabetes mellitus during hypoglycemia.
Enoksson S; Caprio SK; Rife F; Shulman GI; Tamborlane WV; Sherwin RS
J Clin Endocrinol Metab; 2003 Apr; 88(4):1503-11. PubMed ID: 12679430
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic receptors are a fallible index of adrenergic denervation hypersensitivity.
Dejgaard A; Liggett SB; Christensen NJ; Cryer PE; Hilsted J
Scand J Clin Lab Invest; 1991 Dec; 51(8):659-66. PubMed ID: 1666931
[TBL] [Abstract][Full Text] [Related]
10. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].
Berlan M; Lafontan M; Dang Tran L
J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915
[TBL] [Abstract][Full Text] [Related]
11. Effects of autonomic neuropathy on glucose, fatty acid, and ketone body metabolism following insulin withdrawal in patients with insulin-dependent diabetes.
Krentz AJ; Singh BM; Wright AD; Nattrass M
J Diabetes Complications; 1994; 8(2):105-10. PubMed ID: 8061346
[TBL] [Abstract][Full Text] [Related]
12. Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: assessment by analysis of beta and alpha 2 adrenoceptor properties.
Berlan M; Lafontan M
Eur J Clin Invest; 1985 Dec; 15(6):341-8. PubMed ID: 3007159
[TBL] [Abstract][Full Text] [Related]
13. Importance of beta-adrenoceptor function in fat cells for lipid mobilization.
Wahrenberg H; Lönnqvist F; Hellmér J; Arner P
Eur J Clin Invest; 1992 Jun; 22(6):412-9. PubMed ID: 1321722
[TBL] [Abstract][Full Text] [Related]
14. In situ studies of catecholamine-induced lipolysis in human adipose tissue using microdialysis.
Arner P; Kriegholm E; Engfeldt P
J Pharmacol Exp Ther; 1990 Jul; 254(1):284-8. PubMed ID: 2164095
[TBL] [Abstract][Full Text] [Related]
15. Decreased alpha 2-adrenergic receptors on platelet membranes from diabetic patients with autonomic neuropathy and orthostatic hypotension.
Abrahm DR; Hollingsworth PJ; Smith CB; Jim L; Zucker LB; Sobotka PA; Vinik AI
J Clin Endocrinol Metab; 1986 Oct; 63(4):906-12. PubMed ID: 3018030
[TBL] [Abstract][Full Text] [Related]
16. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
Lönnqvist F; Wahrenberg H; Hellström L; Reynisdottir S; Arner P
J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
[TBL] [Abstract][Full Text] [Related]
17. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life.
Marcus C; Karpe B; Bolme P; Sonnenfeld T; Arner P
J Clin Invest; 1987 Jun; 79(6):1812-8. PubMed ID: 3034983
[TBL] [Abstract][Full Text] [Related]
18. Lipolytic response of fat cells to catecholamines in sedentary and exercise-trained women.
Riviere D; Crampes F; Beauville M; Garrigues M
J Appl Physiol (1985); 1989 Jan; 66(1):330-5. PubMed ID: 2537283
[TBL] [Abstract][Full Text] [Related]
19. Drop in the "atypical" beta-adrenergic response and modification of the beta/alpha 2-adrenoceptor balance in fat cells from aging rabbits.
Langin D; Portillo M; Dauzats M; Lafontan M
Endocrinology; 1992 Jan; 130(1):307-15. PubMed ID: 1309335
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
Hellmér J; Marcus C; Sonnenfeld T; Arner P
J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
